Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Methyl 2-amino-4-pentenoate hydrochloride, also known as MAPH, is a chemical compound that serves as a versatile intermediate in the synthesis of pharmaceutical products. It is a derivative of pentenoic acid, featuring an amino group attached to the second carbon of its five-carbon chain. This structural attribute endows MAPH with the capacity to engage in a broad spectrum of chemical reactions, positioning it as a valuable asset in the realms of chemistry and pharmacology.

115289-55-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 115289-55-9 Structure
  • Basic information

    1. Product Name: Methyl 2-aMinopent-4-enoate hydrochloride
    2. Synonyms: Methyl 2-aMinopent-4-enoate hydrochloride;2-Amino-pent-4-enoic acid methyl ester hydrochloride;RS-Allylglycine methyl ester hydrochloride
    3. CAS NO:115289-55-9
    4. Molecular Formula: C6H12NO2*Cl
    5. Molecular Weight: 165.61798
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 115289-55-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: Inert atmosphere,Room Temperature
    8. Solubility: N/A
    9. CAS DataBase Reference: Methyl 2-aMinopent-4-enoate hydrochloride(CAS DataBase Reference)
    10. NIST Chemistry Reference: Methyl 2-aMinopent-4-enoate hydrochloride(115289-55-9)
    11. EPA Substance Registry System: Methyl 2-aMinopent-4-enoate hydrochloride(115289-55-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 115289-55-9(Hazardous Substances Data)

115289-55-9 Usage

Uses

Used in Pharmaceutical Synthesis:
Methyl 2-amino-4-pentenoate hydrochloride is used as a key intermediate in the production of various medications and organic compounds. Its unique structure allows it to participate in a wide range of chemical reactions, facilitating the creation of diverse pharmaceutical entities.
Used in Research Chemicals Development:
Methyl 2-amino-4-pentenoate hydrochloride is utilized as a component in the development of research chemicals. Its reactivity and structural features make it instrumental in advancing biochemical studies and exploring new avenues in chemical research.
Used in Biochemical Studies:
In the field of biochemistry, MAPH is employed for its potential to contribute to the understanding of biochemical processes and the synthesis of bioactive molecules. Its role in these studies is crucial for the advancement of knowledge and the development of new therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 115289-55-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,2,8 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 115289-55:
(8*1)+(7*1)+(6*5)+(5*2)+(4*8)+(3*9)+(2*5)+(1*5)=129
129 % 10 = 9
So 115289-55-9 is a valid CAS Registry Number.

115289-55-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-aminopent-4-enoate,hydrochloride

1.2 Other means of identification

Product number -
Other names DL-C-allylglycine methylester hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:115289-55-9 SDS

115289-55-9Relevant articles and documents

The synthesis of new dibenzothiophen amino acid and cyclophane derivatives

Bremner, John B.,Keller, Paul A.,Pyne, Stephen G.,Robertson, Alan D.,Skelton, Brian W.,White, Allan H.,Witchard, Helen M.

, p. 535 - 540 (2000)

Some novel dibenzothiophen amino acid and cyclophane derivatives have been produced as a result of synthetic studies on the development of dibenzothiophen-based antibacterial compounds. Allylation through a Stille reaction has produced 2-allyl-8-bromodibenzothiophen (3a) and 2,8-diallyldibenzothiophen (3b). Under different conditions, the Stille reaction also produced 2-bromo-8-(prop-1-enyl)dibenzothiophen (4a) and 2,8-di(prop-1-enyl)dibenzothiophen (4b) via double bond isomerization. Olefin metathesis with (3b) and methyl N-acetylallylglycinate (5) produced two homodimers, the novel [4](5,11)[4](18,24)dibenzothiophenophane-2,15-diene (6), as a mixture of geometrical isomers, and dimethyl (E)- and (Z)-(R,S)-2,7-diacetamidooct-4-enedioate (8), and the two cross-metathesis products methyl (E)- and (Z)-(R,S)-2-acetamido-6-(8-allyldibenzothien-2-yl)hex-4-enoate (7a) and dimethyl (E)- and (Z)-(R,S)-6,6′-(dibenzothiophen-2,8-diyl)bis(2-acetamidohex-4-enoate) (7b). Palladium-catalysed hydrogenation of the homodimer (6) and the cross-metathesis products (7a,b) yielded the corresponding reduced compounds (9) and (10a,b), respectively. CSIRO 2000.

Stereodivergent Synthesis of Carbocyclic Quaternary α-Amino Acid Derivatives Containing Two Contiguous Stereocenters

Bai, Tian,Dong, Xiu-Qin,Fu, Cong,He, Ling,Wang, Chun-Jiang,Xiao, Lu,Xiong, Qi,Zhang, Zongpeng

supporting information, (2022/02/23)

A novel approach to stereodivergent synthesis of carbocyclic α-quaternary amino acid derivatives, bearing two contiguous stereocenters, is proposed through sequential dual Cu/Ir-catalyzed asymmetric allylation and ring-closing metathesis. A variety of five and six-membered carbocyclic α-quaternary amino acid derivatives could be readily achieved in good to high yields with exclusive regioselectivities, excellent diastereoselectivities (13: 1- > 20: 1 dr) and enantioselectivities (generally >99% ee). Of particular note is that the current protocol is also a versatile synthetic tool for the stereodivergent construction of the challenging seven and eight-membered carbocyclic α-amino acid derivatives. All four stereoisomers of these important molecules could be precisely synthesized through the permutation of chiral Cu/Ir catalytic system. The power of this strategy has been demonstrated for the facile access to some biologically active chiral molecules, such as spiro-hydantoins.

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

-

Page/Page column, (2014/05/25)

Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria.

Isothiourea-catalyzed enantioselective carboxy group transfer

Joannesse, Caroline,Johnston, Craig P.,Concellon, Carmen,Simal, Carmen,Philp, Douglas,Smith, Andrew D.

supporting information; experimental part, p. 8914 - 8918 (2010/02/28)

Transferable skills: Enantiomerically pure isothioureas promote the 0-to C-carboxyl group transfer of oxazolyl carbonates with excellent levels of enantiocontrol (see scheme). The origin of the enantioselectivity of this process was probed mechanistically and rationalized computationally.

Gold-catalyzed cycloisomerizations of ene-ynamides

Couty, Sylvain,Meyer, Christophe,Cossy, Janine

experimental part, p. 1809 - 1832 (2009/06/28)

The gold-catalyzed cycloisomerizations of 1,6-ene-ynamides proceed under mild conditions and lead to cyclobutanones from terminal or trimethylsilyl substituted ynamides, or to carbonyl compounds bearing a 2,3-methanopyrrolidine subunit from substrates pos

BRIDGED ARYL PIPERAZINES DERIVATIVES USEFUL FOR THE TREATMENT OF CNS, GI-URINARY AND REPRODUCTIVE DISORDERS

-

Page/Page column 21, (2010/11/30)

The present invention is directed to bridged aryl piperazine derivatives, pharmaceutical compositions containing them and their use in the treatment of depression and related disorders. The compounds of the present invention are serotonin transport inhibi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 115289-55-9